GRAIL, Inc. (NASDAQ:GRAL) Receives Average Recommendation of “Hold” from Brokerages

GRAIL, Inc. (NASDAQ:GRAL) has been given a consensus recommendation of “Hold” by the ten brokerages that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation and four have given a buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $67.7778.

Several research analysts recently issued reports on GRAL shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of GRAIL in a research report on Friday, July 17th. Wolfe Research started coverage on GRAIL in a report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. TD Cowen reaffirmed a “buy” rating on shares of GRAIL in a research report on Wednesday, July 15th. Wall Street Zen cut GRAIL from a “hold” rating to a “sell” rating in a research report on Saturday. Finally, The Goldman Sachs Group began coverage on GRAIL in a research note on Friday, June 5th. They issued a “neutral” rating and a $60.00 price objective for the company.

Insider Activity

In other GRAIL news, CFO Aaron Freidin sold 7,900 shares of GRAIL stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $85.01, for a total value of $671,579.00. Following the sale, the chief financial officer owned 253,083 shares of the company’s stock, valued at approximately $21,514,585.83. The trade was a 3.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Joshua J. Ofman sold 5,000 shares of the business’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $85.02, for a total transaction of $425,100.00. Following the completion of the transaction, the chief executive officer owned 397,271 shares in the company, valued at approximately $33,775,980.42. The trade was a 1.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.83% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On GRAIL

A number of hedge funds have recently modified their holdings of GRAL. Bank of America Corp DE grew its holdings in GRAIL by 29.0% during the first quarter. Bank of America Corp DE now owns 914,114 shares of the company’s stock valued at $47,241,000 after purchasing an additional 205,611 shares during the period. Russell Investments Group Ltd. lifted its position in shares of GRAIL by 255.6% during the 2nd quarter. Russell Investments Group Ltd. now owns 28,403 shares of the company’s stock valued at $1,939,000 after buying an additional 20,416 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in shares of GRAIL by 154,361.0% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 91,132 shares of the company’s stock worth $7,531,000 after acquiring an additional 91,073 shares during the period. Vanguard Group Inc. grew its stake in shares of GRAIL by 9.0% during the 4th quarter. Vanguard Group Inc. now owns 1,980,783 shares of the company’s stock worth $169,535,000 after acquiring an additional 163,790 shares during the period. Finally, WIM INVESTMENT MANAGEMENT Ltd increased its holdings in GRAIL by 68.9% in the 4th quarter. WIM INVESTMENT MANAGEMENT Ltd now owns 106,400 shares of the company’s stock worth $9,107,000 after acquiring an additional 43,400 shares during the last quarter.

GRAIL Stock Performance

Shares of GRAL stock opened at $80.34 on Monday. The firm has a fifty day simple moving average of $72.54 and a two-hundred day simple moving average of $62.72. GRAIL has a 12 month low of $33.61 and a 12 month high of $118.84. The firm has a market capitalization of $3.59 billion, a PE ratio of -8.24 and a beta of 3.25.

GRAIL (NASDAQ:GRAL) last released its quarterly earnings data on Wednesday, August 5th. The company reported ($2.56) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.66) by $0.10. The firm had revenue of $44.69 million for the quarter, compared to analyst estimates of $42.39 million. GRAIL had a negative net margin of 236.95% and a negative return on equity of 15.88%. On average, equities analysts predict that GRAIL will post -10.41 earnings per share for the current fiscal year.

About GRAIL

GRAIL, Inc (NASDAQ: GRAL) is a biotechnology company dedicated to the early detection of cancer through a multi-cancer blood test. Leveraging advances in next-generation sequencing, cell-free DNA (cfDNA) analysis and machine learning, GRAIL has developed the Galleri™ test, which aims to identify more than 50 types of cancer at their earliest stages. The company’s platform analyzes methylation patterns in circulating tumor DNA to pinpoint tumor presence and tissue of origin, enabling physicians to pursue timely diagnostic follow-up.

Founded in 2016 as a spin-out from Illumina, GRAIL established its headquarters in Menlo Park, California, with additional research and operations centers in the United Kingdom.